Pharmacoeconomic evaluation acceptability of clopidogrelversus acetylsalicylic acid in patients with cardiovascular disease for stroke prevention in Ukraine

dc.contributor.authorMishchenko, Oksana
dc.contributor.authorIakovlieva, Larysa
dc.contributor.authorAdonkina, Viktoriya
dc.contributor.authorKyrychenko, Olga
dc.contributor.authorGerasymova, Olga
dc.date.accessioned2013-12-19T13:45:32Z
dc.date.available2013-12-19T13:45:32Z
dc.date.issued2013-11
dc.identifier.citationPharmacoeconomic evaluation acceptability of clopidogrel versus acetylsalicylic acid in patients with cardiovascular disease for stroke prevention in Ukraine : [ISPOR 16th Annual European Congress, 2–6 november 2013, Dublin, Ireland] / O. Mishchenko, L. Iakovlieva, V. Adonkina, O. Kyrychenko, O. Gerasymovа // Value in Health. – 2013. – V. 16, № 7. – P. A525.uk_UA
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/5319
dc.language.isoenuk_UA
dc.subjectpharmacoeconomic evaluationuk_UA
dc.subjectclopidogreluk_UA
dc.subjectacetylsalicylic aciduk_UA
dc.subjectstroke preventionuk_UA
dc.titlePharmacoeconomic evaluation acceptability of clopidogrelversus acetylsalicylic acid in patients with cardiovascular disease for stroke prevention in Ukraineuk_UA
dc.typeArticleuk_UA

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Pharmacoeconomic evaluation acceptability of clopidogrel versus.doc
Size:
28 KB
Format:
Microsoft Word

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6.52 KB
Format:
Item-specific license agreed upon to submission
Description: